The FDA has expanded the approval of Evkeeza® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia.
A new phishing and malware distribution toolkit called MatrixPDF allows attackers to convert ordinary PDF files into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback